Public Health Initiative on Alcohol Flushing (AIAC)

April 22, 2026 updated by: Kevin Chang, Stanford University

A Public Health Education and Awareness Initiative on Alcohol Flushing and Alcohol-related Cancer in Asian Communities

The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population.

The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol consumption behavior.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Palo Alto, California, United States, 94304
        • Stanford University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult age over 18
  • Native English speaker

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Genotype Revealed
Subjects with ALDH2 mutation will be notified of positive genotype results after testing completed.
Genetic: ALDH2 Genotyping
Cheek swab for PCR testing of ALDH2 genotype.
Placebo Comparator: Gentoype Not-Revealed
Subjects with ALDH2 mutation will not be notified of positive genotype results until after study completed.
Genetic: ALDH2 Genotyping
Cheek swab for PCR testing of ALDH2 genotype.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol Consumption Habits 1
Time Frame: Baseline, 1 month, 3 month
Number of days alcohol was consumed in past 30 days
Baseline, 1 month, 3 month
Alcohol Consumption Habits 2
Time Frame: Baseline, 1 month, 3 month
Number of days 2 or more drinks of alcohol was consumed in past 30 days
Baseline, 1 month, 3 month
Alcohol Consumption Habits 3
Time Frame: Baseline, 1 month, 3 month
Average number of alcohol consumed on days alcohol was consumed
Baseline, 1 month, 3 month
Alcohol Consumption Habits 4
Time Frame: Baseline, 1 month, 3 month
Largest number of drinks of alcohol consumed in one sitting
Baseline, 1 month, 3 month
Alcohol Flushing Awareness
Time Frame: Baseline, 1 month, 3 month
Alcohol flushing reaction awareness questionnaire, scale from 0 to 4, higher score is better outcome
Baseline, 1 month, 3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Stanford University

Collaborators

Stanford Center for Asian Health Research and Education

Investigators

  • Principal Investigator: Kevin Chang, MD, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 25, 2024

Primary Completion (Actual)

April 25, 2024

Study Completion (Actual)

April 25, 2024

Study Registration Dates

First Submitted

April 29, 2024

First Submitted That Met QC Criteria

May 1, 2024

First Posted (Actual)

May 3, 2024

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 22, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 71764

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Toxicity

Clinical Trials on ALDH2 Genotyping

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe